Related references
Note: Only part of the references are listed.Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes
Sierra C. Marker et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor
Chiara Riganti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand
Leonor Corte-Real et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio et al.
MOLECULES (2019)
Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological Effect
Leonor Corte-Real et al.
INORGANIC CHEMISTRY (2019)
Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance
Yuanyuan Liu et al.
BIOMACROMOLECULES (2019)
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells
Christine C. Gana et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny et al.
CHEMICAL REVIEWS (2019)
Methyl-cyclopentadienyl Ruthenium Compounds with 2,2′-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential
Leonor Corte-Real et al.
INORGANIC CHEMISTRY (2018)
Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells
Kee W. Tan et al.
DRUG METABOLISM AND DISPOSITION (2018)
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
Venus Sosa Iglesias et al.
FRONTIERS IN ONCOLOGY (2018)
Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer
Gabriella Spengler et al.
ANTICANCER RESEARCH (2018)
A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro
Kaushik Banerjee et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
Navin Sarin et al.
PLOS ONE (2017)
Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding
Huifang Peng et al.
ONCOTARGET (2017)
New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers
Betty Yuen Kwan Law et al.
ONCOTARGET (2017)
Selection and characterization of a human ovarian cancer cell line resistant to auranofin
Ida Landini et al.
ONCOTARGET (2017)
Valproic Acid-Functionalized Cyclometalated Iridium(III)Complexes as Mitochondria-Targeting Anticancer Agents
Rui-Rong Ye et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1
Lauriane Dury et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds
Tania S. Morais et al.
FUTURE MEDICINAL CHEMISTRY (2016)
MRP1 and its role in anticancer drug resistance
Jamie F. Lu et al.
DRUG METABOLISM REVIEWS (2015)
The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds
Leonor Corte-Real et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
A novel class of ruthenium-based photosensitizers effectively kills in vitro cancer cells and in vivo tumors
Jamie Fong et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2015)
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells
Joanna Kopecka et al.
ONCOTARGET (2015)
Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance
Gergely Szakacs et al.
CHEMICAL REVIEWS (2014)
Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
Yao-Rong Zheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition
Joanna Kopecka et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Synthesis and characterization of MHa⟨-HOR dihydrogen bonded ruthenium and osmium complexes (η5-C5H4CH2OH)MH(PPh3)2 (M = Ru, Os)
Bai Wei et al.
SCIENCE CHINA-CHEMISTRY (2014)
The molecular interaction of a copper chelate with human P-glycoprotein
Ruma Dey Ghosh et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer
Ruma Dey Ghosh et al.
DALTON TRANSACTIONS (2011)
Conjugation of Organoruthenium(II) 3-(1H-Benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and Indolo[3,2-d]benzazepines to Recombinant Human Serum Albumin: a Strategy To Enhance Cytotoxicity in Cancer Cells
Iryna N. Stepanenko et al.
INORGANIC CHEMISTRY (2011)
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
Anne Auperin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate
Avishek Ganguly et al.
PLOS ONE (2010)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs
Wee Han Ang et al.
CHEMMEDCHEM (2007)
Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms
Carsten A. Vock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
